Who owns Corvus Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CRVS from SEC Form 13F filings across 177 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 177 institutions disclosed 68.8M shares of Corvus Pharmaceuticals, Inc. worth $792.4M — about 74.4% of shares outstanding; the largest disclosed holder is ORBIMED ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
177
13F holders
$792.4M
value, 2026 filers
74.4%
of shares outstanding (68.8M sh)
26
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CRVS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 7.2M | $82.5M | 1.5% | 7.7% | 0.0% |
| 2 | BlackRock, Inc. | 7.1M | $81.8M | 0.0% | 7.7% | -0.5% |
| 3 | STATE STREET CORP | 3.3M | $38.4M | 0.0% | 3.6% | -25.5% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 3.3M | $38.2M | 0.0% | 3.6% | +0.8% |
| 5 | Hood River Capital Management LLC | 3.3M | $38.2M | 0.3% | 3.6% | +110.8% |
| 6 | ADAMS STREET PARTNERS LLC | 3.3M | $37.7M | 11.0% | 3.5% | 0.0% |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.1M | $35.2M | 0.0% | 3.3% | -19.3% |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | 2.9M | $32.9M | 0.0% | 3.1% | +4.4% |
| 9 | Vivo Capital, LLC | 2.8M | $32.3M | 3.6% | 3% | 0.0% |
| 10 | PERCEPTIVE ADVISORS LLC | 2.5M | $28.9M | 0.5% | 2.7% | -5.9% |
| 11 | Deep Track Capital, LP | 2.5M | $28.7M | 0.5% | 2.7% | 0.0% |
| 12 | BRAIDWELL LP | 1.9M | $22.2M | 0.9% | 2.1% | -9.2% |
| 13 | Foresite Capital Management VI LLC | 1.8M | $21.1M | 3.7% | 2% | 0.0% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $20.7M | 0.0% | 1.9% | -3.0% |
| 15 | Fisher Asset Management, LLCNEW | 1.0M | $12.0M | 0.0% | 1.1% | new |
| 16 | Catalio Capital Management, LP | 1.0M | $11.8M | 2.2% | 1.1% | -5.5% |
| 17 | MORGAN STANLEY | 792,714 | $9.1M | 0.0% | 0.9% | -41.1% |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | 787,558 | $9.1M | 0.0% | 0.9% | -3.3% |
| 19 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $8.6M | 0.0% | 0.8% | 0.0% |
| 20 | TWO SIGMA INVESTMENTS, LP | 708,566 | $8.2M | 0.0% | 0.8% | -9.8% |
| 21 | EMERALD ADVISERS, LLC | 680,016 | $7.8M | 0.2% | 0.7% | -0.8% |
| 22 | GOLDMAN SACHS GROUP INC | 647,024 | $7.5M | 0.0% | 0.7% | -59.0% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 642,526 | $7.4M | 0.0% | 0.7% | +208.7% |
| 24 | DCF Advisers, LLC | 641,500 | $7.4M | 1.7% | 0.7% | +0.6% |
| 25 | MILLENNIUM MANAGEMENT LLC | 605,644 | $7.0M | 0.0% | 0.7% | -42.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.